28 results on '"Hirayama, Fukushi"'
Search Results
2. Novel strategy to boost oral anticoagulant activity of blood coagulation enzyme inhibitors based on biotransformation into hydrophilic conjugates
3. Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist
4. Prodrug-based design, synthesis, and biological evaluation of N-benzenesulfonylpiperidine derivatives as novel, orally active factor Xa inhibitors
5. Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands
6. Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand
7. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist
8. Synthesis and biological activity of novel 1,2-disubstituted benzene derivatives as factor Xa inhibitors
9. Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives
10. Synthesis and biological activity of novel 1,4-diazepane derivatives as factor Xa inhibitor with potent anticoagulant and antithrombotic activity
11. Design, synthesis and biological activity of YM-60828 derivatives. Part 2: potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template
12. Design, synthesis and biological activity of YM-60828 derivatives: potent and orally-Bioavailable factor Xa inhibitors based on naphthoanilide and naphthalensulfonanilide templates
13. The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor
14. One‐Pot Synthetic Procedure for2,2′‐Disubstituted Biaryls via the Suzuki Coupling Reaction of Aryl Triflates in a Biphasic Solvent System.
15. Antithrombotic effects of YM466, a synthesized direct inhibitor of factor Xa, in an arterio-venous shunt thrombosis model in squirrel monkeys.
16. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
17. Comparison of YM150, an Oral, Direct Factor Xa Inhibitor, with Other Antithrombotic Agents in Rodent Venous and Arterial Thrombosis Models.
18. Effects of Direct Factor Xa Inhibitor, YM150, on Clot Formation and Clot Lysis In Vitro Compared with Other Anticoagulants.
19. YM477, a Novel Orally-Active Thrombopoietin Receptor Agonist.
20. One-Pot Synthetic Procedure for 2,2′-Disubstituted Biaryls via the Suzuki Coupling Reaction of Aryl Triflates in a Biphasic Solvent System.
21. An Easy to 7-Methyl-2-naphthalenecarbonitrile.
22. ChemInform Abstract: The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor.
23. Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice
24. 4-Aminopyridine-2,3-dicarboxylic acid from Clitocybe acromelalga
25. P-203 - Comparison of YM-60828, a Newly Synthesized factor Xa Inhibitor, and SC-54701A, a Selective GPIIb/IIIa Antagonist: Antithrombotic Activity in Three Thrombosis Models in Guinea Pigs
26. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis
27. Discovery of N-[2-hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (darexaban, YM150) as a potent and orally available factor Xa inhibitor.
28. An easy access to 7-methyl-2-naphthalenecarbonitrile.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.